May 29, 2015
Article
Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) today announced that they have entered into a clinical trial collaboration to evaluate safety and preliminary efficacy of their products.
May 28, 2015
Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology.
Johnson & Johnson (NYSE: JNJ) today announced the acceptance of the March 1, 2015 binding offer from Cardinal Health to acquire its Cordis business for an approximate value of $2 billion.
May 27, 2015
Later this week, Cardinal Health Specialty Solutions will present a new series of health economic outcomes research (HEOR) studies.
Initiative supported by Actavis aims to help advance evidence-based treatment practices using unique data-sharing platform.
May 26, 2015
AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that it has completed the acquisition of Pharmacyclics, Inc.